338 related articles for article (PubMed ID: 29330755)
1. [Lymphoma in rheumatic diseases].
Rubbert-Roth A; Bittenbring JT; Assmann G
Z Rheumatol; 2017 Oct; 76(Suppl 2):46-56. PubMed ID: 29330755
[TBL] [Abstract][Full Text] [Related]
2. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases.
Lisitsyna TA; Veltishchev DY; Seravina OF; Kovalevskaya OB; Starovoytova MN; Desinova OV; Abramkin AA; Ovcharov PS; Vasil'ev VI; Alekberova ZS; Krasnov VN; Nasonov EL
Ter Arkh; 2018 May; 90(5):30-37. PubMed ID: 30701894
[TBL] [Abstract][Full Text] [Related]
4. Suspected inflammatory rheumatic diseases in patients presenting with skin rashes.
Alves F; Gonçalo M
Best Pract Res Clin Rheumatol; 2019 Aug; 33(4):101440. PubMed ID: 31585842
[TBL] [Abstract][Full Text] [Related]
5. Autophagy in Rheumatic Diseases: Role in the Pathogenesis and Therapeutic Approaches.
Celia AI; Colafrancesco S; Barbati C; Alessandri C; Conti F
Cells; 2022 Apr; 11(8):. PubMed ID: 35456038
[TBL] [Abstract][Full Text] [Related]
6. Primary Sjögren's syndrome.
Bowman SJ
Lupus; 2018 Oct; 27(1_suppl):32-35. PubMed ID: 30452329
[TBL] [Abstract][Full Text] [Related]
7. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
[TBL] [Abstract][Full Text] [Related]
8. Malignant lymphoma in patients with systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and dermatomyositis): a clinicopathologic study of 24 Japanese cases.
Kojima M; Itoh H; Shimizu K; Saruki N; Murayama K; Higuchi K; Tamaki Y; Matsumoto M; Hirabayashi K; Igarishi S; Masawa N; Nakamura S
Int J Surg Pathol; 2006 Jan; 14(1):43-8. PubMed ID: 16501834
[TBL] [Abstract][Full Text] [Related]
9. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
Smedby KE; Baecklund E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
[TBL] [Abstract][Full Text] [Related]
10. Mucosa-associated lymphoid tissue lymphomas in two patients with rheumatoid arthritis on second-line agents, and secondary Sjögren's syndrome.
Sutcliffe N; Smith C; Speight PM; Isenberg DA
Rheumatology (Oxford); 2000 Feb; 39(2):185-8. PubMed ID: 10725070
[TBL] [Abstract][Full Text] [Related]
11. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
12. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
[TBL] [Abstract][Full Text] [Related]
13. Rheumatic disease patients, prone to Sjögren's syndrome and/or lymphoma, mount an antibody response to BHRF1, the Epstein-Barr viral homologue of BCL-2.
Newkirk MM; Shiroky JB; Johnson N; Danoff D; Isenberg DA; Shustik C; Pearson GR
Br J Rheumatol; 1996 Nov; 35(11):1075-81. PubMed ID: 8948292
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
[TBL] [Abstract][Full Text] [Related]
15. Relationship of systemic lupus erythematosus (SLE) to rheumatoid arthritis (RA), discoid lupus erythematosus (DLE) and Sjögren's syndrome. A clinical study.
Bencze G
Acta Rheumatol Scand; 1970; 16(3):191-6. PubMed ID: 5488864
[No Abstract] [Full Text] [Related]
16. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of patients with rheumatic diseases and abnormal liver function].
Wu CY; Li MC; Duan XW; Li HB; Wang YH; Li Q; Luo H; Xu J; Wu LJ; Wang YF; Zhao C; Fang YF; Lin SD; Xu D; Tian XP; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2023 Sep; 62(9):1102-1113. PubMed ID: 37650184
[No Abstract] [Full Text] [Related]
18. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
De Jesus A; Talal N
Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
[TBL] [Abstract][Full Text] [Related]
19. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
20. What rheumatologists should know about orofacial manifestations of autoimmune rheumatic diseases.
Abrão AL; Santana CM; Bezerra AC; Amorim RF; Silva MB; Mota LM; Falcão DP
Rev Bras Reumatol Engl Ed; 2016; 56(5):441-450. PubMed ID: 27692394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]